Under its partnership with Aproplan, Exquando delivered a first installation to GSK Vaccines at a construction site of a new vaccines production unit in Wavre.
2012 has been an exciting year for Exquando, marked by many strategic decision and the acquisition of new customers.
GSK Biologicals recently announced its decision to entrust Exquando with a three-year collaboration.
Exquando selected as Preferred Supplier for profiles in document management by a leading pharmaceutical company.
At the Extraordinary General Meeting held this January 30, 2015, Philippe Braibant was appointed Independent Director of Exquando.
We do not collect personal data via this website. Every data provided to us through the contact forms of this website is used to facilitate routine contact and operational work.
Data is held securely and is subject to access controls.
For any question related to our Data Protection Policies and process, please contact us at